Related references
Note: Only part of the references are listed.Enhanced anti-tumor response elicited by a novel oncolytic HSV-1 engineered with an anti-PD-1 antibody
Chao Tian et al.
CANCER LETTERS (2021)
The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
Shunchuan Zhang et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity
Sang-In Kim et al.
MOLECULAR CANCER THERAPEUTICS (2021)
ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
Brian B. Haines et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
Sharmila Nair et al.
JCI INSIGHT (2021)
Crosstalk between oncolytic viruses and autophagy in cancer therapy
Ke-Tao Jin et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma
Jianhan Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
Bo Xu et al.
NATURE COMMUNICATIONS (2021)
Measles Virus as an Oncolytic Immunotherapy
Christine E. Engeland et al.
CANCERS (2021)
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1
Riikka Havunen et al.
CELLS (2021)
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
Yalei Zhang et al.
CANCER CELL INTERNATIONAL (2021)
Mesenchymal stem cell carriers enhance antitumor efficacy induced by oncolytic reovirus in acute myeloid leukemia
Xianyao Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer
Ali Zahedi-Amiri et al.
CELLS (2021)
Current strategies in engaging oncolytic viruses with antitumor immunity
Drew Ashton Boagni et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation
Kotaro Sugawara et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
Tomoyoshi Inoue et al.
MOLECULAR CANCER THERAPEUTICS (2021)
The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
Ifeanyi Kingsley Uche et al.
VIRUSES-BASEL (2021)
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes
Alexander Malogolovkin et al.
VIRUSES-BASEL (2021)
Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma
John D. Christie et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells
Sara L. Seegers et al.
JOURNAL OF VIROLOGY (2020)
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines
Gayathri Vijayakumar et al.
JOURNAL OF VIROLOGY (2020)
Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
Caroline E. Porter et al.
MOLECULAR THERAPY (2020)
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
Jenna H. Newman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
Feng Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Oncolytic Virotherapy with Myxoma Virus
Masmudur M. Rahman et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
Hong-My Nguyen et al.
CELLS (2020)
Enhancing therapeutic efficacy of oncolytic vaccinia virus armed with Beclin-1, an autophagic Gene in leukemia and myeloma
Wen Lei et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Jessica Wenthe et al.
CANCER GENE THERAPY (2020)
Modeling the Spatiotemporal Dynamics of Oncolytic Viruses and Radiotherapy as a Treatment for Cancer
Eman Simbawa et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2020)
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity
Adrian Pelin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses
Thirupandiyur S. Udayakumar et al.
MOLECULAR CANCER RESEARCH (2020)
Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways
Masmudur M. Rahman et al.
VACCINES (2020)
Virotherapy: From single agents to combinatorial treatments
Anna Maria Malfitano et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent
Rodolfo Chicas-Sett et al.
CANCERS (2020)
Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
Shyambabu Chaurasiya et al.
CANCERS (2020)
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy
Zong Sheng Guo et al.
BIOMEDICINES (2020)
Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells
Ahmed Ghdhban Al-Ziaydi et al.
CANCER CELL INTERNATIONAL (2020)
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
Chang-Myung Oh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model
Mohamed Hammad et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Clinical landscape of oncolytic virus research in 2020
Nicholas Macedo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Cell death signalling in virus infection
Gergely Imre
CELLULAR SIGNALLING (2020)
Cytokines in oncolytic virotherapy
Jonathan G. Pol et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
June Kyu Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting immunogenic cell death in cancer
Asma Ahmed et al.
MOLECULAR ONCOLOGY (2020)
NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy
Yvonne Cornejo et al.
Oncotarget (2020)
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Bin Zhang et al.
MOLECULAR CANCER (2020)
Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
Jing Cai et al.
CANCER CELL INTERNATIONAL (2020)
Oncolytic viruses: overcoming translational challenges
Jordi Martinez-Quintanilla et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer
Rachael Mooney et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival
Patrick Kellish et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Praveen K. Bommareddy et al.
ONCOIMMUNOLOGY (2019)
Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
Naiara Martinez-Velez et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety
Steven S. Raman et al.
IMMUNOTHERAPY (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer
A. J. Robert McGray et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples
Eleanor M. Scott et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Sergei S. Zaindiutnov et al.
ONCOLYTIC VIROTHERAPY (2019)
Armed oncolytic viruses: A kick-start for anti-tumor immunity
J. F. de Graaf et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2018)
Fighting Cancer with Viruses: Oncolytic Virus Therapy in China
Ding Wei et al.
HUMAN GENE THERAPY (2018)
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Dmitriy Zamarin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer
Tuo Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
The advent of oncolytic virotherapy in oncology: The Rigvir® story
Peteris Alberts et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses
Olga V. Matveeva et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
Xiao-Qin Liu et al.
DRUG DELIVERY (2018)
Recombinant Viruses for Cancer Therapy
Daria S. Chulpanova et al.
BIOMEDICINES (2018)
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Christopher J. LaRocca et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Oncolytic virus-induced cell death and immunity: a match made in heaven?
Jolien De Munck et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Poxviruses Utilize Multiple Strategies to Inhibit Apoptosis
Daniel Brian Nichols et al.
VIRUSES-BASEL (2017)
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
Pengju Wang et al.
NATURE COMMUNICATIONS (2017)
Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors
Alicia M. Waters et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2017)
Oncolytic Viruses in Cancer Treatment A Review
Sean E. Lawler et al.
JAMA ONCOLOGY (2017)
Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization
Sean M. O'Cathail et al.
FRONTIERS IN ONCOLOGY (2017)
Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cells
Y. Furukawa et al.
CANCER GENE THERAPY (2017)
Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma
Loren K. Mell et al.
CLINICAL CANCER RESEARCH (2017)
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson et al.
CLINICAL CANCER RESEARCH (2017)
A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models
Jian Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein
Liang-Tzung Lin et al.
VIRUSES-BASEL (2016)
Arming oncolytic viruses to leverage antitumor immunity
Tanja D. de Gruijl et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Norman Woller et al.
MOLECULAR THERAPY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Stealing the Keys to the Kitchen: Viral Manipulation of the Host Cell Metabolic Network
Christopher M. Goodwin et al.
TRENDS IN MICROBIOLOGY (2015)
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions
Janice Kim et al.
VIRUSES-BASEL (2015)
Going viral: a review of replication-selective oncolytic adenoviruses
Christopher Larson et al.
ONCOTARGET (2015)
Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma
Chunyan Li et al.
ONCOTARGET (2015)
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil
Larissa A. Pikor et al.
TRENDS IN CANCER (2015)
Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
Alexander Muik et al.
CANCER RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
Christine E. Engeland et al.
MOLECULAR THERAPY (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates
Justin C. Roth et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach et al.
CANCER RESEARCH (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
Zaheed Husain et al.
JOURNAL OF IMMUNOLOGY (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia
Yin Tong et al.
ONCOTARGET (2013)
Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
Chunchun Meng et al.
ARCHIVES OF VIROLOGY (2012)
Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses
Emma Borrego-Diaz et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity
Rohann J. M. Correa et al.
GYNECOLOGIC ONCOLOGY (2012)
Effect of γ34.5 Deletions on Oncolytic Herpes Simplex Virus Activity in Brain Tumors
Ryuichi Kanai et al.
JOURNAL OF VIROLOGY (2012)
Myxoma Virus Sensitizes Cancer Cells to Gemcitabine and Is an Effective Oncolytic Virotherapeutic in Models of Disseminated Pancreatic Cancer
Sonia Tusell Wennier et al.
MOLECULAR THERAPY (2012)
Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response
Marie Beneteau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
Jun Li et al.
MOLECULAR THERAPY (2011)
Adenoviruses induce autophagy to promote virus replication and oncolysis
Humberto Rodriguez-Rocha et al.
VIROLOGY (2011)
Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
Guido Wollmann et al.
JOURNAL OF VIROLOGY (2010)
Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
Jennifer Altomonte et al.
MOLECULAR THERAPY (2010)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma
Ta-Chiang Liu et al.
MOLECULAR THERAPY (2008)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity
Zhenkun Yu et al.
MOLECULAR THERAPY (2007)
History of oncolytic viruses: Genesis to genetic engineering
Elizabeth Kelly et al.
MOLECULAR THERAPY (2007)
Oncolytic measles virus targets high CD46 expression on multiple myeloma cells
Hooi Tin Ong et al.
EXPERIMENTAL HEMATOLOGY (2006)
Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor
G Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector
TD McKee et al.
CANCER RESEARCH (2006)
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
BD Anderson et al.
CANCER RESEARCH (2004)
Complexes of poliovirus serotypes with their common cellular receptor, CD155
YN He et al.
JOURNAL OF VIROLOGY (2003)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Share Paper
